Get started
Author

Jiasi Vicky Zhang

Locally secreted BiTEs complement CAR T cells by enhancing killing of antigen heterogeneous solid tumors
2022 · Yibo Yin, Jesse L. Rodriguez, et al. · Molecular Therapy · 107
Armored bicistronic CAR T cells with dominant-negative TGF-β receptor II to overcome resistance in glioblastoma
2024 · Nannan Li, Jesse L. Rodriguez, et al. · Molecular Therapy · 74
PDF
Single-cell RNA-seq-based proteogenomics identifies glioblastoma-specific transposable elements encoding HLA-I-presented peptides
2022 · Pierre-Emmanuel Bonté, Yago A. Arribas, et al. · Cell Reports · 74
High-Affinity Chimeric Antigen Receptor With Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms
2021 · Radhika Thokala, Zev A. Binder, et al. · Frontiers in Oncology · 37
PDF
Immunologic Features in De Novo and Recurrent Glioblastoma Are Associated with Survival Outcomes
2022 · Cécile Alanio, Zev A. Binder, et al. · Cancer Immunology Research · 24
PDF
Selective removal of misfolded SOD1 delays disease onset in a mouse model of amyotrophic lateral sclerosis
2023 · Teng Guan, Ting Zhou, et al. · Cellular and Molecular Life Sciences · 20
PDF
Neurofilament Light Chain Related to Longitudinal Decline in Frontotemporal Lobar Degeneration
2020 · Jiasi Vicky Zhang, David J. Irwin, et al. · Neurology Clinical Practice · 7
Abstract LB138: Natural killer cell-based signaling in EGFR-targeted KIR-CAR T overcomes CD3-based CAR T functional deficits to eliminate resistant glioblastomas in vivo
2026 · Jun Xu, Radhika Thokala, et al. · Cancer Research · 1
Locally secreted BiTEs complement CAR T cells by enhancing solid tumor killing
2021 · Yibo Yin, Jesse L. Rodriguez, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Data from Immunologic Features in De Novo and Recurrent Glioblastoma Are Associated with Survival Outcomes
2023 · Cécile Alanio, Zev A. Binder, et al.
Data from Immunologic Features in De Novo and Recurrent Glioblastoma Are Associated with Survival Outcomes
2023 · Cécile Alanio, Zev A. Binder, et al.
Supplementary Figure from Immunologic Features in De Novo and Recurrent Glioblastoma Are Associated with Survival Outcomes
2023 · Cécile Alanio, Zev A. Binder, et al.
PDF
Supplementary Figure from Immunologic Features in De Novo and Recurrent Glioblastoma Are Associated with Survival Outcomes
2023 · Cécile Alanio, Zev A. Binder, et al.
Works count: 13
Citation count: 345
H-index: 7
I10-index: 6
Year
Topic
Type